Scientists have taken another important step toward restoring vision in people with certain inherited forms of blindness. In ...
After the liquidation of MSEC, new rules apply: we analyze the visual acuity indicators for establishing Group III disability ...
The Vestibular Disorders Association (VeDA) honors Thomas Brandt, MD, FACP and Eric Anson, PT, PhD, as the recipient of ...
New research on service academy cadets shows that a single short night of sleep measurably degrades computerized concussion ...
ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has defined as supportive of potential approval Atsena also ...
Detecting impaired motor function in infants using AI-driven motion capture is producing promising results. A French research ...
Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthal ...
SZN-8141 is a bifunctional Wnt agonist and vascular endothelial growth factor (VEGF) antagonist antibody being developed as an intravitreal injection for the treatment of diabetic macular edema (DME).
Is it possible to receive disability group II with multiple diseases and what important points to consider during the ...
October is a month with many eye-related anniversaries, such as 'Glasses Day' (the 1st), 'Eye Care Day' (the 10th), and 'Wink ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results